AREV Life Sciences Global (AREV Life Sciences Global) GF Value : $0.02 (As of Jun. 24, 2024)

View and export this data going back to 2019. Start your Free Trial

What is AREV Life Sciences Global GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-24), AREV Life Sciences Global's share price is $0.028. AREV Life Sciences Global's GF Value is $0.02. Therefore, AREV Life Sciences Global's Price-to-GF-Value for today is 1.40.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes AREV Life Sciences Global is Significantly Overvalued.

AREV Life Sciences Global (OTCPK:AREVF) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

AREV Life Sciences Global's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.028	/	0.02
	=	1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AREV Life Sciences Global GF Value Related Terms

Thank you for viewing the detailed overview of AREV Life Sciences Global's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

AREV Life Sciences Global (AREV Life Sciences Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AREV Life Sciences Global Corp (OTCPK:AREVF) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

91 Golden Drive, Unit 18, Coquitlam, BC, CAN, V3K 6R2

Website

https://www.arevlifesciences.com

AREV Life Sciences Global Corp is a fully integrated, early stage life science discovery enterprise dedicated to delivering solutions to public healthcare metrics through innovations and successful collaborations in the life science industry. The Company's focuses on dedication to generate revenue by way of novel therapeutic approaches to human nutrition and malnutrition, pandemic diseases, and neglected chronic co-morbidities.

AREV Life Sciences Global (AREV Life Sciences Global) Headlines

From GuruFocus

Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering

By GuruFocusNews GuruFocusNews • 04-21-2022

AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development

By GuruFocusNews GuruFocusNews • 04-21-2022

AREV Life Sciences Completes Lab and Fungi Fruiting Room Build

By GuruFocusNews GuruFocusNews • 02-23-2022

AREV Life Sciences Advances Developments, New Appointments and Relationships

By GuruFocusNews GuruFocusNews • 02-17-2022